Kopp Family Office, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 29, 2024), Kopp Family Office, LLC reported 21 stock positions worth $161.2 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 18.8% of the portfolio, followed by iShares Russell 2000 ETF (IWM, 14.5%) and Vericel (VCEL, 13.0%). Compared with Q1 2024, it opened 1 new position, sold out of 1, added to 9 and reduced 3. The biggest buy was a new position in Nutanix Class A (NTNX) and the biggest sale an exit from Model N (MODN).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $161.2M (Q2 2024)
- SEC Filing
- 0001683689-24-000004 ↗ filed Jul 29, 2024
Holdings Value
Holdings 21 stocks · $161.2M
| VEA Vanguard Ftse Developed ETF | 18.83% | 614,265 | $30.4M | Reduce -0.7% |
| IWM iShares Russell 2000 ETF | 14.48% | 88,905 | $23.3M | Reduce -16.3% |
| VCEL Vericel Corp. | 13.03% | 457,678 | $21.0M | Add +0.0% |
| VWO Vanguard Ftse Emerging Marke | 10.81% | 398,285 | $17.4M | Reduce -0.6% |
| FIVN FIVE9 Inc. | 9.63% | 352,075 | $15.5M | Add +48.3% |
| NEO Neogenomics Inc. | 8.13% | 944,775 | $13.1M | Add +5.6% |
| TEAM Atlassian Corp. Ltd. Class A | 5.45% | 49,694 | $8.8M | Add +0.0% |
| WK Workiva Inc. | 5.06% | 111,708 | $8.2M | Add +46.2% |
| JAMF Jamf Holding Corp. filed as JAMF HLDG CORP | 4.12% | 402,519 | $6.6M | Add +0.0% |
| NTNX Nutanix Inc. Class A | 3.44% | 97,664 | $5.6M | New |
| INSP Inspire Medical Systems Inc. | 3.41% | 41,065 | $5.5M | Add +0.0% |
| VRDN Viridian Therapeutics Inc. | 1.66% | 205,737 | $2.7M | Add +0.1% |
| MITK Mitek Systems Inc. | 1.64% | 236,937 | $2.6M | Add +0.0% |
| IVV iShares Core S&P 500 ETF | 0.07% | 197 | $108K | No change |
| IEFA iShares Core MSCI Eafe ETF | 0.06% | 1,400 | $102K | No change |
| ISTB iShares Core 1-5 Year Usd Bo | 0.06% | 2,015 | $95K | No change |
| IEMG iShares Core MSCI Emerging | 0.04% | 1,150 | $62K | No change |
| IAGG iShares Intl Aggregate Bond | 0.02% | 806 | $40K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.02% | 834 | $36K | No change |
| IJH iShares Core S&P Midcap ETF | 0.02% | 565 | $33K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 164 | $17K | No change |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
| NTNX Nutanix Inc. Class A | New | 3.44% | +3.44 |
| WK Workiva Inc. | Add +46.2% | 5.06% | +1.36 |
| FIVN FIVE9 Inc. | Add +48.3% | 9.63% | +1.21 |
| NEO Neogenomics Inc. | Add +5.6% | 8.13% | +0.10 |
| TEAM Atlassian Corp. Ltd. Class A | Add +0.0% | 5.45% | −0.08 |
| JAMF Jamf Holding Corp. | Add +0.0% | 4.12% | −0.10 |
| MITK Mitek Systems Inc. | Add +0.0% | 1.64% | −0.26 |
| VRDN Viridian Therapeutics Inc. | Add +0.1% | 1.66% | −0.40 |
| VCEL Vericel Corp. | Add +0.0% | 13.03% | −0.57 |
| INSP Inspire Medical Systems Inc. | Add +0.0% | 3.41% | −1.63 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |